Bachem Investor Relations Material
Latest events
H1 2025
Bachem
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bachem Holding AG
Access all reports
Bachem Holding AG develops and manufactures peptides and oligonucleotides for the pharmaceutical and biotechnology industries. The company offers products and services for research, clinical development, and commercial-scale production of active pharmaceutical ingredients. It supports customers with custom synthesis and contract manufacturing. The company is headquartered in Bubendorf, Switzerland, and its shares are listed on the SIX.
Key slides for Bachem Holding AG
CMD 2024
Bachem Holding AG
H2 2024
Bachem Holding AG
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BANB
Country
🇨🇭 Switzerland